Cormorant Private Healthcare Fund V LP insider trades: BlossomHill Therapeutics (BLSM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cormorant Private Healthcare Fund V LP reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM | ↑ Buy | 312,500 | $16.00 | $5.0M | Indirect | Aug 10, 2026 (0d) |
| May 15, 2025 | OKUR | ↓ Sell | 1,813,439 | $1.85 | $3.4M | Indirect | May 19, 2025 (4d) |
| May 12, 2025 | OKUR | ↓ Sell | 24,300 | $1.99 | $48K | Indirect | May 14, 2025 (2d) |
| Sep 27, 2024 | BIOA | ↑ Buy | 450,000 | $18.00 | $8.1M | Indirect | Oct 1, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BLSM insiders
Open-market trades in the last 12 months
About Cormorant Private Healthcare Fund V LP's insider trades
Cormorant Private Healthcare Fund V LP is a 10% owner of BlossomHill Therapeutics (BLSM). Since Sep 27, 2024, it has reported 2 open-market purchases worth $13.1M and 2 sales worth $3.4M on SEC Form 4. In the last 12 months: 1 buy ($5.0M).
Its filings also include conversions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.